Wednesday, July 18, 2007
Martin Bonde Joins the Board
The Board of MycoTeQ has again been strengthened considerably – we are very delighted to announce that Martin Bonde has joined the Board.
Martin Bonde knows the biotech industry inside out. He is currently the CEO of NatImmune A/S and has previously held management positions in several biotech companies in Denmark and in the US. He has been involved in a number of investment rounds, trade sales, licensing deals etc. in his career and brings many valuable insights with him into MycoTeQ.
On behalf of the management group I would like to welcome Martin Bonde and thank him for joining the MycoTeQ Board.
- Henrik
Martin Bonde knows the biotech industry inside out. He is currently the CEO of NatImmune A/S and has previously held management positions in several biotech companies in Denmark and in the US. He has been involved in a number of investment rounds, trade sales, licensing deals etc. in his career and brings many valuable insights with him into MycoTeQ.
On behalf of the management group I would like to welcome Martin Bonde and thank him for joining the MycoTeQ Board.
- Henrik
Friday, March 02, 2007
Poul Rasmussen Joins the Board
We are very pleased to announce that Poul Rasmussen has joined the Board of MycoTeQ.
Poul Rasmussen has more than 30 years of experience from the pharmaceutical industry and is currently the Chairman of the Board at LEO Pharma as well as Executive Vice President, R&D (also LEO Pharma), and member of the Institute Counsil at Statens Serum Institute (SSI).
Having Poul Rasmussen on the Board is a huge step forward for MycoTeQ. His expertise, experience and network will play an important role in our future work. A warm welcome to Poul from the management group.
Poul Rasmussen has more than 30 years of experience from the pharmaceutical industry and is currently the Chairman of the Board at LEO Pharma as well as Executive Vice President, R&D (also LEO Pharma), and member of the Institute Counsil at Statens Serum Institute (SSI).
Having Poul Rasmussen on the Board is a huge step forward for MycoTeQ. His expertise, experience and network will play an important role in our future work. A warm welcome to Poul from the management group.
Monday, January 08, 2007
MycoTeQ and 2007
Happy New Year!
2006 was a very interesting year for all of us involved in the creation of MycoTeQ. We know now that it was worthwhile - MycoTeQ was founded late autumn and activities in the labs started shortly after. A great success for everyone involved.
I am sure 2007 will be just as demanding and rewarding. The amount of hard work and fun will again be incredible - but the tasks will in many aspects be quite different: Consolidation of the Board of Directors, investor relations program, second round of efficacy testing of lead compound, service program specification, improving customer base etc. We look forward to work with all these interesting and important matters and all the other things that pop up along the road.
The MycoTeQ Management wishes everyone the best for 2007.
2006 was a very interesting year for all of us involved in the creation of MycoTeQ. We know now that it was worthwhile - MycoTeQ was founded late autumn and activities in the labs started shortly after. A great success for everyone involved.
I am sure 2007 will be just as demanding and rewarding. The amount of hard work and fun will again be incredible - but the tasks will in many aspects be quite different: Consolidation of the Board of Directors, investor relations program, second round of efficacy testing of lead compound, service program specification, improving customer base etc. We look forward to work with all these interesting and important matters and all the other things that pop up along the road.
The MycoTeQ Management wishes everyone the best for 2007.
Friday, December 01, 2006
Start of small scale production
We are now fully up running - it feels great.
The first priority has been to get our small scale production up running. A few days ago we completed the first batch run and the results were very satisfying. The current production will continue full steam ahead the next weeks - and perhaps until mid January.
Also the legal aspects of founding the company have occupied quite a bit of the management resources recently. All major contracts were signed last week and it is fantastic to be able to focus on the really value adding activities now.
- Henrik
The first priority has been to get our small scale production up running. A few days ago we completed the first batch run and the results were very satisfying. The current production will continue full steam ahead the next weeks - and perhaps until mid January.
Also the legal aspects of founding the company have occupied quite a bit of the management resources recently. All major contracts were signed last week and it is fantastic to be able to focus on the really value adding activities now.
- Henrik
Tuesday, October 10, 2006
Starting up the MycoTeQ Blog
This blog is where the managment group of MycoTeQ will comment on subjects that are on our mind.
The company is still in the very early phase - we have only just recieved funding from the very first investor and all communication systems and logistics in general are still in the phase of establishment.
We hope you will enjoy this look into our company and comment if you have anything on your mind. Best regards from the management group.
The company is still in the very early phase - we have only just recieved funding from the very first investor and all communication systems and logistics in general are still in the phase of establishment.
We hope you will enjoy this look into our company and comment if you have anything on your mind. Best regards from the management group.
